Mannatech Inc MTEX
We take great care to ensure that the data presented and summarized in this overview for MANNATECH INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MTEX
Top Purchases
Top Sells
About MTEX
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Insider Transactions at MTEX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2025
|
Kevin Andrew Robbins Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,686
+11.13%
|
$37,604
$14.89 P/Share
|
|
Jan 02
2025
|
Larry A Jobe Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,686
+4.47%
|
$37,604
$14.89 P/Share
|
|
Jan 02
2025
|
Robert Toth Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,686
+2.86%
|
$37,604
$14.89 P/Share
|
|
Jan 02
2025
|
J Stanley Fredrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,686
+0.75%
|
$37,604
$14.89 P/Share
|
|
Jan 02
2025
|
Tyler Rameson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,686
+0.88%
|
$37,604
$14.89 P/Share
|
|
Jan 02
2025
|
Seifrick A John Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,686
+23.07%
|
$37,604
$14.89 P/Share
|
|
Sep 09
2024
|
Tyler Rameson Director |
BUY
Open market or private purchase
|
Direct |
16,288
+5.16%
|
$114,016
$7.75 P/Share
|
|
Sep 09
2024
|
Larry A Jobe Director |
SELL
Open market or private sale
|
Direct |
16,288
-22.94%
|
$114,016
$7.75 P/Share
|
|
May 22
2024
|
Larry A Jobe Director |
SELL
Open market or private sale
|
Direct |
1,012
-1.41%
|
$7,084
$7.6 P/Share
|
|
Mar 11
2024
|
Landen Granvel Fredrick COO/Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
8,187
+40.23%
|
$73,683
$9.16 P/Share
|
|
Jan 02
2024
|
Larry A Jobe Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,932
+6.41%
|
$39,456
$8.11 P/Share
|
|
Jan 02
2024
|
Tyler Rameson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,932
+1.71%
|
$39,456
$8.11 P/Share
|
|
Jan 02
2024
|
Kevin Andrew Robbins Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,932
+20.82%
|
$39,456
$8.11 P/Share
|
|
Jan 02
2024
|
Seifrick A John Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,932
+44.03%
|
$39,456
$8.11 P/Share
|
|
Jan 02
2024
|
J Stanley Fredrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,932
+2.11%
|
$39,456
$8.11 P/Share
|
|
Aug 30
2023
|
Alfredo Bala CEO and President |
SELL
Open market or private sale
|
Direct |
1,000
-24.17%
|
$12,000
$12.4 P/Share
|
|
Aug 18
2023
|
Larry A Jobe Director |
SELL
Open market or private sale
|
Direct |
1,217
-1.78%
|
$14,604
$12.82 P/Share
|
|
Jun 30
2023
|
Alfredo Bala CEO and President |
SELL
Open market or private sale
|
Direct |
115
-2.7%
|
$1,380
$12.62 P/Share
|
|
Jun 29
2023
|
Alfredo Bala CEO and President |
SELL
Open market or private sale
|
Direct |
154
-3.5%
|
$1,848
$12.89 P/Share
|
|
Feb 14
2023
|
Landen Granvel Fredrick COO/Interim CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+33.47%
|
$10,000
$5.72 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 24.3K shares |
|---|---|
| Open market or private purchase | 16.3K shares |
| Open market or private sale | 17.3K shares |
|---|